PuSH - Publication Server of Helmholtz Zentrum München: Genetische Prädisposition und Umweltfaktoren in der Pathogenese des Typ-1-Diabetes.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Hummel, S. ; Ziegler, A.-G.

Genetische Prädisposition und Umweltfaktoren in der Pathogenese des Typ-1-Diabetes.

Genetic predisposition and environmental factors in the pathogenesis of type 1 diabetes.

Internist. Prax. 66, 373-383 (2023)

Publ. Version/Full Text

To article

	Closed

Abstract
Metrics
Extra information

Type 1 diabetes (T1D) is one of the most common chronic diseases in childhood caused by autoimmune-mediated destruction of the insulin-producing pancreatic islet ß-cells. Prospective birth cohort studies contributed to the identification of genetic and environmental factors involved in the pathogenesis of type 1 diabetes. The development and validation of a genetic risk score enabled risk prediction for later development of type 1 diabetes. Consistent findings from prospective studies point to the contribution of intrauterine maternal type 1 diabetes exposure, early childhood viral infections, early childhood growth/obesity, and gut microbiome/dysbiosis in the pathogenesis of type 1 diabetes. Launched in late 2017, the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) was designed to carry out newborn screening in the general population, identify infants at high genetic risk of developing type 1 diabetes, and offer them participation in trials to prevent disease initiation.

Impact Factor

Scopus SNIP

0.000

0.001